GNLX - GENELUX Corp
2.8
-0.030 -1.071%
Share volume: 111,330
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.83
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-06-2025 | 11-05-2025 | |
| Assets | |||||||
| Total Assets | 24.676 M | 45.179 M | 40.270 M | 34.716 M | 38.985 M | 24.987 M | |
| Current Assets | 21.204 M | 34.870 M | 35.967 M | 31.548 M | 35.945 M | 21.552 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 15.566 M | 25.778 M | 27.955 M | 22.330 M | 18.896 M | 16.223 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.061 M | 7.858 M | 6.102 M | 8.565 M | 16.206 M | 0.000 | |
| Total Non-current Assets | 0.000 | 6.813 M | 1.003 M | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.116 M | 1.306 M | 1.278 M | 1.316 M | 1.287 M | 1.794 M | |
| Other Assets | 2.356 M | 9.003 M | 3.025 M | 1.852 M | 1.753 M | 1.641 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 24.676 M | 45.179 M | 40.270 M | 34.716 M | 38.985 M | 24.987 M | |
| Total liabilities | 9.592 M | 7.510 M | 7.179 M | 8.442 M | 9.139 M | 6.396 M | |
| Total current liabilities | 7.805 M | 5.803 M | 5.555 M | 6.903 M | 7.689 M | 5.126 M | |
| Accounts Payable | 5.313 M | 4.786 M | 4.454 M | 5.570 M | 6.688 M | 3.987 M | |
| Other liabilities | 1.787 M | 1.707 M | 1.624 M | 1.539 M | 1.450 M | 1.270 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.787 M | 1.707 M | 1.624 M | 1.539 M | 1.450 M | 1.270 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 15.084 M | 37.669 M | 33.091 M | 26.274 M | 29.846 M | 18.591 M | |
| Common stock | 244.896 M | 274.063 M | 275.817 M | 278.036 M | 289.135 M | 293.307 M | |
| Retained earnings | -229.374 M | -235.950 M | -242.417 M | -251.393 M | -258.885 M | -274.291 M |